VISUAL ACUITY REDUCED TRANSIENTLY

This adverse event was reported 308 times

These drugs are most commonly taken by patients reporting VISUAL ACUITY REDUCED TRANSIENTLY:

# Drug Count
0 AFLIBERCEPT 81
1 BROLUCIZUMAB 48
2 RANIBIZUMAB 18
3 BEVACIZUMAB 16
4 ASPIRIN 12
5 ASPIRIN 325 MG 11
6 ASPIRIN 81 MG 11
7 METFORMIN 11
8 PREDNISOLONE 10
9 PREDNISOLONE ORAL 10
See all common drugs associated with VISUAL ACUITY REDUCED TRANSIENTLY

VISUAL ACUITY REDUCED TRANSIENTLY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BROLUCIZUMAB 48 0.0132
1 PROPARACAINE HYDROCHLORIDE 2 0.0037
2 BEPOTASTINE BESILATE 2 0.0031
3 TROPICAMIDE 5 0.0031
4 AVACINCAPTAD PEGOL 1 0.0028
5 AFLIBERCEPT 81 0.0026
6 LOTEPREDNOL ETABONATE AND TOBRAMYCIN 1 0.0025
7 POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL 2 0.0018
8 PEGCETACOPLAN 3 0.0016
9 TOBRAMYCIN AND DEXAMETHASONE 5 0.0015
See all drugs enriched for association with VISUAL ACUITY REDUCED TRANSIENTLY

VISUAL ACUITY REDUCED TRANSIENTLY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Antiseptic [EPC] 6 0.0014
1 alpha-1 Adrenergic Agonist [EPC] 4 0.0009
2 CD30-directed Immunoconjugate [EPC] 6 0.0006
3 Vascular Endothelial Growth Factor Inhibitor [EPC] 98 0.0005
4 Photoenhancer [EPC] 2 0.0005
5 Anticholinergic [EPC] 6 0.0004
6 Carbonic Anhydrase Inhibitor [EPC] 7 0.0003
7 Plasma Volume Expander [EPC] 1 0.0003
8 Quinolone Antimicrobial [EPC] 3 0.0003
9 Anti-anginal [EPC] 3 0.0003
See all drug classes enriched for association with VISUAL ACUITY REDUCED TRANSIENTLY